- Home
- 2020
Elizabeth Engle, OGI Associate Director, inducted into the American Academy of Medicine
November 10, 2020Congratulations to Dr. Engle on her recent induction into the National Academy of Medicine. Elizabeth C. Engle, M.D., investigator, Howard Hughes Medical Institute; professor of neurology and ophthalmology, Harvard Medical School; senior associate in neurology, ophthalmology, and genetics, Boston Children’s Hospital; and associate member,... Read More
The Genetics of and Genetic Therapies for Inherited Retinal Degenerations
October 22, 2020Eric Pierce MD PhD and OGI director participated in the distinguished speaker lecture series organized by the Center For Translational Vision Research at University of California, Irvine in September 2020. You can watch the lecture below. https://youtu.be/uRyAOKuZ928
Rosario Fernandez Godino awarded grant
October 20, 2020The Global Ophthalmology Awards Program from Bayer has awarded a grant to Rosario Fernandez Godino for her project: Studying the impact of ageing and Bruch’s membrane mechanotransduction in age-related macular degeneration (AMD).This proposal aims to bridge the gaps between normal ageing and RPE/Bruch’s membrane pathology to inform... Read More
Improving the throughput of diagnosis and treatment of inherited diseases of the retina
October 7, 2020Dr. Jason Comander was recently awarded a 5 year grant to support his work focused on efficiently identifying the genetic cause of inherited retinal degenerations.(IRDs), an important cause of vision loss. By using cell-based assays to determine the functional significance of a large panel of DNA variants, the goal is to increase the... Read More
First proof of concept for a therapy to treat patients with NMNAT1-associated disease
September 16, 2020Molecular Therapy: Methods & Clinical Development Vol. 18 September 2020 ª 2020 Authors from the Ocular Genomics Institute and Grousebeck Gene therapy Center have published the first proof of concept for a therapy to treat patients with NMNAT1-associated disease. No treatment is available for nicotinamide mononucleotide... Read More
Janey Wiggs Selected to Receive 2022 Weisenfeld Award
September 16, 2020Janey L. Wiggs (Mass Eye and Ear) has been selected by the Association for Research in Vision and Ophthalmology (ARVO) to receive the 2022 Mildred Weisenfeld Award for Excellence in Ophthalmology in recognition of her distinguished scholarly contributions to the clinical practice of ophthalmology. This award was established as a tribute to... Read More
Licensing Agreement with Biogen to Develop Treatment for Inherited Retinal Disorder
August 25, 2020Massachusetts Eye and Ear, a member hospital of Mass General Brigham, is entering into an exclusive licensing agreement with Biogen to develop a potential treatment for inherited retinal degeneration due to mutations in the PRPF31 gene, which are among the most common causes for autosomal dominant retinitis pigmentosa. Inherited retinal... Read More
Kinga M. Bujakowska, PhD, Receives RPB International Research Collaborators Award
August 14, 2020Kinga M. Bujakowska, PhD, a molecular geneticist and Assistant Professor of Ophthalmology at Harvard Medical School, has been awarded the Research to Prevent Blindness 2020 RPB International Research... Read More
Genetic Links Between Glaucoma and Alzheimer’s Disease
August 14, 2020New research led by Drs. Janey Wiggs and Milica Margeta (Mass. Eye and Ear), recently published in Read More
Caitlin Collin, PhD, Awarded Knights Templar Eye Foundation Grant
August 14, 2020Mass. Eye and Ear postdoctoral research fellow Caitlin Collin, PhD, was awarded a Career Starter Grant from the Knights Templar Eye Foundation. The grant will provide $70,000 of support for Dr. Collin’s research on the development of gene editing approaches for ABCA4-associated Stargardt disease. The Knights... Read More
Vandenberghe Lab working on SARS-CoV2 vaccine
June 15, 2020Luk Vandenberghe PhD, Assistant Director of the Ocular Genomics Institute, Director of the Grousbeck Gene Therapy Center at Massachusetts Eye and Ear, and Associate Professor of Ophthalmology at Harvard Medical School is leading the work at Massachusetts Eye and Ear and Massachusetts General Hospital in the development of an experimental... Read More